Marpai (MRAI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
17 Nov, 2025Executive summary
Q3 2025 revenue was $4.0 million, down 42% year-over-year due to customer turnover and market changes.
Net loss for Q3 2025 was $3.5 million, an improvement from $3.6 million in Q3 2024.
Significant operational and financial improvements were achieved through cost discipline and efficiency initiatives.
Leadership is focused on client-centric operations, technology upgrades, and retention, while exploring strategic alternatives including investments, mergers, or a sale.
Positioned for aggressive, sustainable growth in 2026 with a robust sales pipeline and operational stabilization.
Financial highlights
Operating expenses decreased by 24% year-over-year, from $5.0M to $3.8M.
Operating loss improved by 2% to $3.5 million in Q3 2025; net loss per share improved to $(0.20) from $(0.30).
Nine-month 2025 revenue was $14.1 million, down 35% from $21.6 million in 2024.
Operating loss for the nine months was $8.6 million, a 56% improvement from $19.4 million in 2024.
Total assets at September 30, 2025: $12.8M; total liabilities: $46.1M; stockholders' deficit: $(33.3M).
Outlook and guidance
Double-digit new client contracts are booked for January 2026, indicating strong base business growth.
Technology upgrades, operational efficiencies, and integrated PBM offerings are expected to accelerate profitability, with a target of Q1 2026.
Management projects a need for additional capital to fund operations until revenue scales to self-sufficiency, with substantial doubt about going concern.
Latest events from Marpai
- Q2 2024 saw a 28% revenue drop, $13M net loss, and a $7.6M impairment charge.MRAI
Q2 20242 Feb 2026 - Q3 2024 losses narrowed as cost cuts offset revenue decline, but liquidity risks remain.MRAI
Q3 202415 Jan 2026 - Losses narrowed in 2024; new PBM products and partnerships target 2025 profitability.MRAI
Q4 202426 Dec 2025 - Board seeks approval for director elections, auditor ratification, and preferred stock authorization.MRAI
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and preferred stock authorization.MRAI
Proxy Filing2 Dec 2025 - Facing ongoing losses and liquidity risks, the company relies on new capital to sustain operations.MRAI
Registration Filing29 Nov 2025 - Q2 2025 saw revenue drop but major cost cuts, with profitability targeted for early 2026.MRAI
Q2 202523 Nov 2025 - Revenue fell 27% to $5.4M; net loss improved, but liquidity and funding risks remain.MRAI
Q1 202519 Nov 2025